Gainers
Adagio Therapeutics, Inc. (NASDAQ: ADGI) shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price target from Jefferies.
Gainers
Krystal Biotech, Inc. (NASDAQ: KRYS) shares jumped 116.4% to $86.13 after the company announced positive topline results from the GEM-3 Phase 3 trial of investigational beremagene geperpavec (B-VEC, Vyjuvek) for dystrophic Epidermolysis Bullosa (dystrophic EB).
Jefferies initiated coverage of Theseus Pharmaceuticals Inc (NASDAQ:THRX) with a Buy rating and $23 price target, seeing an upside of approximately 32%. …
Cantor Fitzgerald analyst Alethia Young initiates coverage on Theseus Pharmaceuticals (NASDAQ:THRX) with a Overweight rating and announces Price Target of $25.